#United States #Ashland #ABK Biomedical #Eye90 microspheres #COR Development

ABK Biomedical and COR Development Join Forces

ABK Biomedical, Inc. and COR Development have announced an exciting partnership aimed at establishing a cutting-edge manufacturing facility in the heart of Ashland, Missouri. This facility, located in Cartwright Business Park, is designed to support the long-term commercial production of Eye90 microspheres®, a breakthrough technology recognized by the FDA and currently under development for liver cancer treatment.

The construction and design of this high-tech facility will be managed by Coil Construction, renowned for its expertise in specialized commercial building. They will ensure that the plant meets rigorous regulatory and technical standards needed for medical isotope manufacturing. This new site will serve as a pivotal element in ABK Biomedical's global supply chain as it advances towards full-scale production.

Strategic Significance
Mike Mangano, President and CEO of ABK Biomedical, highlighted the importance of this project, stating, "Establishing this commercial footprint is another major milestone for ABK. The Cartwright Business Park provides an ideal location for our long-term manufacturing needs." He also noted that in partnering with COR Development and Coil Construction, the company would have a world-class facility capable of supplying Eye90 microspheres to a rapidly expanding Y90 radioembolization market.

The geographic advantage of the Ashland location cannot be overstated, as it is conveniently situated close to the University of Missouri Research Reactor (MURR®). This facility is the only domestic source for the yttrium-90 (Y-90) radioisotope, essential in the production of Eye90 microspheres. The short distance between the manufacturing plant and the reactor will ensure a reliable and timely supply chain, ultimately benefitting clinicians and improving outcomes for patients with liver cancer.

Economic Growth and Job Creation
Nicholas Orscheln, Managing Member at COR Development, expressed enthusiasm for the collaboration, stating, "Developing this sophisticated life sciences facility within the Cartwright Business Park not only highlights the economic growth of the area but also allows us to build a space that supports life-saving medical innovation." David Coil, President of Coil Construction, also shared his positive outlook, emphasizing their history in the Columbia, MO area and their commitment to high-tech manufacturing.

The upcoming facility will be meticulously designed for the production of Eye90 microspheres, which hold the distinction of being the first and only clinical-stage Y90 radioembolization device capable of multi-modality imaging upon implantation. This innovative feature is set to enhance physicians' capacity to evaluate the implants, thereby improving the accuracy and potential outcomes for patients undergoing treatment.

Moreover, the project is anticipated to create new high-tech employment opportunities in the Columbia area and fortify Missouri's position as a hub for nuclear medicine and biotechnology.

About the Companies
ABK Biomedical, Inc. is dedicated to the research, development, and commercialization of medical device therapies aimed at enhancing treatment outcomes for patients with benign and malignant hypervascular tumors. The company prides itself on its intellectual property related to inorganic polymer microspheres and unique administration systems.

COR Development is known for its integrated approach, providing top-tier talent from site selection to post-development services to deliver premium quality projects.

Coil Construction specializes in commercial, industrial, and institutional construction and is recognized for its exemplary craftsmanship and community-centric projects.

Conclusion

With the establishment of this new facility, ABK Biomedical and COR Development are set to make significant strides in cancer treatment technology, transforming the landscape of medical care for patients with liver cancer while also contributing to local economic growth.